HOME   Cart(0)   Quotation   About-Us Policy PDFs Standard-List
www.ChineseStandard.net Database: 189759 (19 Oct 2025)

YY/T 1910-2023 English PDF

US$219.00 · In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
YY/T 1910-2023: Medical-grade beta-tricalcium phosphate powder for additive manufacturing
Status: Valid
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusPDF
YY/T 1910-2023English219 Add to Cart 3 days [Need to translate] Medical-grade beta-tricalcium phosphate powder for additive manufacturing Valid YY/T 1910-2023

PDF similar to YY/T 1910-2023


Standard similar to YY/T 1910-2023

YY/T 1942   YY/T 1943   YY/T 1897   YY/T 1911   YY/T 1909   

Basic data

Standard ID YY/T 1910-2023 (YY/T1910-2023)
Description (Translated English) Medical-grade beta-tricalcium phosphate powder for additive manufacturing
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C30
Classification of International Standard 11.040.30
Word Count Estimation 11,139
Date of Issue 2023-09-05
Date of Implementation 2024-09-15
Issuing agency(ies) State Drug Administration
Summary This standard specifies the performance requirements, test methods, labeling, packaging, transportation and storage of medical beta-tricalcium phosphate powder for additive manufacturing. This standard applies to medical beta-tricalcium phosphate powder produced by light-curing, extrusion and powder-laying additive manufacturing processes.

YY/T 1910-2023: Medical-grade beta-tricalcium phosphate powder for additive manufacturing

---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.040.30 CCSC30 Pharmaceutical Industry Standards of the People's Republic of China Medical beta-tricalcium phosphate powder for additive manufacturing Published on 2023-09-05 Implemented on 2024-09-15 Released by the State Drug Administration

Table of contents

PrefaceⅠ Introduction II 1 Scope 1 2 Normative reference documents 1 3 Terms and Definitions 1 4 Performance requirements 1 5 Test method 3 6 Labeling, packaging, transportation and storage 4 Appendix A (Normative) β-tricalcium phosphate X-ray diffraction spectrum 5 Reference 6

Foreword

This document complies with the provisions of GB/T 1.1-2020 "Standardization Work Guidelines Part 1.Structure and Drafting Rules of Standardization Documents" Drafting. Please note that some content in this document may be subject to patents. The publisher of this document assumes no responsibility for identifying patents. This document is proposed by the National Medical Products Administration. This document is under the jurisdiction of the China Institute for Food and Drug Control. This document was drafted by. Dianyun Biotechnology (Hangzhou) Co., Ltd., China Institute of Food and Drug Control, Maihai New Material Technology (Gu'an) Co., Ltd., Northwestern Polytechnical University, Zhejiang University of Science and Technology, South China University of Technology Medical Device Research and Inspection Center, Sichuan Medical Device Biomaterials and Products Inspection Center Co., Ltd., Tianjin Medical Device Quality Supervision and Inspection Center, National Human Tissue Function Reconstruction Engineering Technology Research Center Center, Zhejiang Institute of Medical Device Inspection, Shanghai Biolu Biomaterials Co., Ltd., Zhejiang Epuri Nano New Materials Co., Ltd., Suzhou Ding'an Technology Co., Ltd. The main drafters of this document. Zeng Qingfeng, Wei Jing, Han Qianqian, Mao Xin, Liu Zhenqi, Yu Shuyin, Liu Yongsheng, Kong Xiangdong, Liu Jia, Deng Xiang, Ma Chunbao, Ren Li, Xu Pinghua, Lu Xiao, Ni Chenghui, Li Yadong.

Introduction

Medical β-tricalcium phosphate powder is suitable for a variety of additive manufacturing processes, such as stereolithography, binder injection, powder bed fusion and extrusion. Craftsmanship. Due to different additive manufacturing processes, the particle size and distribution, powder morphology, specific surface area, bulk density, and vibration of medical β-tricalcium phosphate powder are affected. The requirements for solid density and fluidity are different, so it needs to be controlled based on the specific process type and product quality requirements. Medical beta-tricalcium phosphate powder for additive manufacturing

1 Scope

This document specifies the performance requirements, test methods, labeling, packaging, transportation and Storage. This document applies to medical beta-tricalcium phosphate powder produced by light-curing, extrusion and powder-laying additive manufacturing processes.

2 Normative reference documents

The contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, the dated quotations For undated referenced documents, only the version corresponding to that date applies to this document; for undated referenced documents, the latest version (including all amendments) applies to this document. GB/T 19077 Particle size distribution laser diffraction method GB/T 19587 Determination of specific surface area of solid materials by gas adsorption BET method GB 23101.3 Hydroxyapatite for surgical implants Part 3.Chemical analysis and characterization of crystallinity and phase purity GB/T 35021 Additive manufacturing process classification and raw materials GB/T 35351 Additive Manufacturing Terminology GB/T 39696 Standard funnel method for determination of flowability of fine ceramic powders YY/T 0683-2008 β-tricalcium phosphate for surgical implants ISO 23145-1 Determination of bulk density of fine ceramics (advanced ceramics, high-tech ceramics) ceramic powders Part 1.Tap density ceramicpowders-Part 1.Tapdensity] ISO 23145-2 Determination of bulk density of fine ceramics (advanced ceramics, high-tech ceramics) ceramic powders Part 2.Uncompacted dense ceramicpowders-Part 2.Untappeddensity] Pharmacopoeia of the People's Republic of China (2020 edition, four volumes)

3 Terms and definitions

The terms and definitions defined in GB/T 35021 and GB/T 35351 apply to this document.

4 Performance requirements

4.1 Appearance It should be white powder with no visible colored matter. 4.2 X-ray diffraction It should be consistent with the characteristic peaks in the X-ray diffraction spectrum of β-tricalcium phosphate in Appendix A [diffraction angles (2θ) are approximately 27.8°, 31.0°, and 34.4° respectively] consistent.

Tips & Frequently Asked Questions:

Question 1: How long will the true-PDF of YY/T 1910-2023_English be delivered?

Answer: Upon your order, we will start to translate YY/T 1910-2023_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time.

Question 2: Can I share the purchased PDF of YY/T 1910-2023_English with my colleagues?

Answer: Yes. The purchased PDF of YY/T 1910-2023_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.

Question 3: Does the price include tax/VAT?

Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countries

Question 4: Do you accept my currency other than USD?

Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.